Name | Mobocertinib succinate |
---|---|
Synonyms | MFCD32689632 |
Description | Mobocertinib succinate (compound A) is a potent epidermal growth factor receptor (EGFR) inhibitor and an antineoplastic agent, extracted from patent WO2019222093A1, compound A[1][2]. |
---|---|
Related Catalog | |
References |
[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). |
Molecular Formula | C36H45N7O8 |
---|---|
Molecular Weight | 703.78 |